# Phase II Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-ii-study-of-temsirolimus-cci-779-a-novel-inhibitor-of-mtor-in-heavily/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Stephen Chan,M. E. Scheulen,S. Johnston,K. Mross,Fátima Cardoso,Christian Dittrich,W. Eiermann,Dagmar Hess,Rudolph Morant,Semiglazov Vf,Markus Borner,Marc Salzberg,Valerijus Ostapenko,H. J. Illiger,Dirk Behringer,Nathalie Bardy‐Bouxin,Joseph Boni,Steven Kong,Maria Cincotta,Laurence Moore |
| Citations | 469 |
| DOI | 10.1200/jco.2005.66.130 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.66.130?role=tab |
| OpenAlex ID | https://openalex.org/W2112001957 |
| PMID | 15955899 |
| Type | article |
| Year | 2005 |

## Paper authors

- [W. Eiermann](https://scholariq.org/researchers/w-eiermann/)
- [Laurence Moore](https://scholariq.org/researchers/laurence-moore/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Paper topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.